SCHEMBL231289

SCHEMBL231289

C=CCN(C(C)C)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL31456221 0.97 MEN1 (0.33) MEN1KMT2A
SCHEMBL27730043 0.97 MEN1 (0.33) MEN1KMT2A
SCHEMBL21897534 0.84 MEN1 (0.37) MEN1KMT2A
SCHEMBL22454201 0.84 MEN1 (0.30) MEN1KMT2A
SCHEMBL19329839 0.77
SCHEMBL16531806 0.77 MEN1 (0.32) MEN1KMT2A
SCHEMBL170618 0.77 MEN1 (0.32) MEN1KMT2A
SCHEMBL1248737 0.77
SCHEMBL1137481 0.75 MEN1 (0.33) MEN1KMT2A
SCHEMBL9900354 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2528864-B1 METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS Ndsu res found (US) 2017-03-29 EP claimed
US-8975429-B2 Method of producing cyclohexasilane compounds NDSU RESEARCH FOUNDATION (US) 2015-03-10 US claimed
EP-2528864-A1 METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS Ndsu Research Foundation (US) 2012-12-05 EP claimed
US-20120294791-A1 METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS NDSU RESEARCH FOUNDATION 2012-11-22 US claimed
WO-2011094191-A1 METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS NDSU RESEARCH FOUNDATION (US) 2011-08-04 WO claimed
US-20110015245-A1 BENDAMUSTINE AMPHIPHILIC CATIONIC COMPOSITIONS SUPRATEK PHARMA INC. (CA) 2011-01-20 US claimed
EP-0882700-A2 Process for the production of the dexfenfluramine hydrochloride ALFA CHEMICALS ITALIANA S.p.A. (IT) 1998-12-09 EP claimed
US-5481038-A Borane-N,N-diisopropylalkylamine hydroboration agents ALDRICH CHEMICAL COMPANY, INC. (US) 1996-01-02 US claimed
EP-0467727-B1 Esterification process of hydroxybenzoic acids RHONE POULENC CHIMIE (FR) 1995-09-13 EP claimed
US-5260475-A Esterification of hydroxybenzoic acids RHONE-POULENC CHIMIE (FR) 1993-11-09 US claimed
US-5210305-A Process for preparing n-alkylanilines and n-allylanilines RHONE-POULENC CHIMIE (FR) 1993-05-11 US claimed
US-5189220-A Reacting aniline and derivatives with alkyl/allyl halides or sulfates in a solvent in presence of alkali metal iodide or onium iodide and a nonqurtenizable base RHONE-POULENC CHIMIE (FR) 1993-02-23 US claimed
US-5132460-A Contacting an aniline with alkyl or alkenyl halide in presence of non-quaternizable tertiary amine and salt of non-quaternizable tertiary amine RHONE-POULENC CHIMIE (FR) 1992-07-21 US claimed
EP-0353131-B1 PROCESS FOR THE PREPARATION OF N-ALKYL AND N-ALLYL ANILINES RHONE-POULENC CHIMIE (FR) 1992-04-15 EP claimed
EP-0353130-B1 PROCESS FOR THE PREPARATION OF N-ALLYL AND N-ALKYL ANILINES CATALYSED BY IODIDES RHONE-POULENC CHIMIE (FR) 1992-04-15 EP claimed
EP-0467727-A1 Esterification process of hydroxybenzoic acids RHONE-POULENC CHIMIE (FR) 1992-01-22 EP claimed
EP-0463922-A1 Process for the esterification of carboxylic acids RHONE-POULENC CHIMIE (FR) 1992-01-02 EP claimed
EP-0353130-A1 Process for the preparation of N-allyl and N-alkyl anilines catalysed by iodides RHONE-POULENC CHIMIE (FR) 1990-01-31 EP claimed
EP-0353131-A1 Process for the preparation of N-alkyl and N-allyl anilines RHONE-POULENC CHIMIE (FR) 1990-01-31 EP claimed
US-12296325-B2 Catalyst for hydrosilylation reaction, hydrogenation reaction, and hydrosilane reduction reaction KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2025-05-13 US disclosed
US-20240148696-A1 LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION SOFTKEMO PHARMA INC. (CA) 2024-05-09 US disclosed
WO-2024091826-A1 LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION SOFTKEMO PHARMA INC. (CA) 2024-05-02 WO disclosed
US-20230241594-A1 CATALYST FOR HYDROSILYLATION REACTION, HYDROGENATION REACTION, AND HYDROSILANE REDUCTION REACTION KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-08-03 US disclosed
EP-3590596-B1 CATALYST FOR HYDROSILYLATION REACTION, HYDROGENATION REACTION, AND HYDROSILANE REDUCTION REACTION UNIV KYUSHU NAT UNIV CORP (JP) 2023-07-12 EP disclosed
US-20220401938-A1 CATALYST FOR HYDROSILYLATION REACTION, HYDROGENATION REACTION, AND HYDROSILANE REDUCTION REACTION KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2022-12-22 US disclosed
US-20220389133-A1 METALLOCENE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2022-12-08 US disclosed
CN-110366449-B Catalyst for hydrosilylation, hydrogenation, and hydrosilane reduction 国立大学法人九州大学 2022-10-21 CN disclosed
EP-4053175-A1 METALLOCENE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF China Petroleum & Chemical Corporation (CN) 2022-09-07 EP disclosed
US-20200368355-A1 FORMULATIONS OF BENDAMUSTINE EAGLE PHARMACEUTICALS, INC. (US) 2020-11-26 US disclosed
CN-106938990-B A method of by allyl tertiary amine compounds one-step synthesis cyano tertiary amine compounds 北京理工大学 2019-09-17 CN disclosed
EP-2847242-B1 CARBINOL-TERMINATED POLYMERS CONTAINING ALLYLAMINE ARLANXEO DEUTSCHLAND GMBH (DE) 2019-07-10 EP disclosed
US-20180185488-A1 FORMULATIONS OF BENDAMUSTINE EAGLE PHARMACEUTICALS INC (US) 2018-07-05 US disclosed
EP-2792369-B1 Bendamustine cyclopolysaccharide compositions SOFTKEMO PHARMA CORP (CA) 2018-04-18 EP disclosed
US-20170349675-A1 NEW POLYOLEFIN CATALYST AND USE THEREOF SHANGHAI CHEMRUN CO. LTD. (CN) 2017-12-07 US disclosed
US-9718912-B2 Carbinol-terminated polymers containing allylamine ARLANXEO DEUTSCHLAND GMBH (DE) 2017-08-01 US disclosed
CN-106938990-A A kind of method by pi-allyl tertiary amine compounds one-step synthesis cyano group tertiary amine compounds 北京理工大学 2017-07-11 CN disclosed
CN-104876861-B Method for producing 2-chloro nicotinic acid 上海泰禾国际贸易有限公司 2017-05-24 CN disclosed
US-9657030-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-05-23 US disclosed
US-9657030-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-05-23 US disclosed
US-9657030-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-05-23 US disclosed
US-9624232-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-04-18 US disclosed
US-9624232-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-04-18 US disclosed
US-9624232-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-04-18 US disclosed
EP-2528864-B1 METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS Ndsu res found (US) 2017-03-29 EP disclosed
US-9593124-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-03-14 US disclosed
US-9593124-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-03-14 US disclosed
US-9593124-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2017-03-14 US disclosed
US-9499557-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2016-11-22 US disclosed
US-9499557-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2016-11-22 US disclosed
US-9499557-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2016-11-22 US disclosed
EP-2995614-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF Rhodes Technologies Inc. (US) 2016-03-16 EP disclosed
US-20150353568-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150353567-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150353567-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150353567-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150353569-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150353569-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150353568-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150353568-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150353569-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-12-10 US disclosed
US-20150336972-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-11-26 US disclosed
US-20150336972-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-11-26 US disclosed
US-20150336972-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF NORAMCO, LLC 2015-11-26 US disclosed
US-9127014-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2015-09-08 US disclosed
US-9127014-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2015-09-08 US disclosed
US-9127014-B2 Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof RHODES TECHNOLOGIES (US) 2015-09-08 US disclosed
US-20150118429-A1 CARBINOL-TERMINATED POLYMERS CONTAINING ALLYLAMINE ARLANXEO DEUTSCHLAND GMBH (DE) 2015-04-30 US disclosed
EP-2847242-A1 CARBINOL-TERMINATED POLYMERS CONTAINING ALLYLAMINE LANXESS Deutschland GmbH (DE) 2015-03-18 EP disclosed
US-8975429-B2 Method of producing cyclohexasilane compounds NDSU RESEARCH FOUNDATION (US) 2015-03-10 US disclosed
CN-104271619-A methanol-terminated polymers containing allylamine LANXESS DEUTSCHLAND GMBH 2015-01-07 CN disclosed
EP-2792369-A1 Bendamustine cyclopolysaccharide compositions SUPRATEK PHARMA, INC. (CA) 2014-10-22 EP disclosed
EP-2400987-B1 BENDAMUSTINE CYCLOPOLYSACCHARIDE COMPOSITIONS SUPRATEK PHARMA INC (CA) 2014-09-03 EP disclosed
US-8703964-B2 Bendamustine cyclopolysaccharide compositions SUPRATEK PHARMA INC. (CA) 2014-04-22 US disclosed
US-8658829-B2 Method of producing polyalkylated oligoalkylenepolyamines NDSU RESEARCH FOUNDATION (US) 2014-02-25 US disclosed
WO-2013167410-A1 CARBINOL-TERMINATED POLYMERS CONTAINING ALLYLAMINE LANXESS DEUTSCHLAND GMBH (DE) 2013-11-14 WO disclosed
EP-2662392-A1 Carbinol-terminated polymers containing allylamine LANXESS Deutschland GmbH (DE) 2013-11-13 EP disclosed
CN-102421451-B Bendamustine cyclopolysaccharide compositions SUPRATEK PHARMA INC 2013-11-06 CN disclosed
US-20130190372-A1 BENDAMUSTINE CYCLOPOLYSACCHARIDE COMPOSITIONS SUPRATEK PHARMA INC. (CA) 2013-07-25 US disclosed
US-8436032-B2 Bendamustine cyclopolysaccharide compositions SUPRATEK PHARMA INC. (CA) 2013-05-07 US disclosed
US-20130102780-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF RHODES TECHNOLOGIES (US) 2013-04-25 US disclosed
US-20130102780-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF RHODES TECHNOLOGIES (US) 2013-04-25 US disclosed
US-20130102780-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF RHODES TECHNOLOGIES (US) 2013-04-25 US disclosed
WO-2013024495-A1 PHARMACEUTICAL FORMULATIONS OF CABAZITAXEL DR. REDDYS LABORATORIES LIMITED (IN) 2013-02-21 WO disclosed
CN-102935080-A Bendamustine cyclopolysaccharide compositions SUPRATEK PHARMA INC 2013-02-20 CN disclosed
US-20120316201-A1 NOVEL BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AND USE THEREOF AS A MEDICAMENT IPSEN PHARMA S.A.S. (FR) 2012-12-13 US disclosed
EP-2528864-A1 METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS Ndsu Research Foundation (US) 2012-12-05 EP disclosed
US-20120294791-A1 METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS NDSU RESEARCH FOUNDATION 2012-11-22 US disclosed
US-20120289748-A1 METHOD OF PRODUCING POLYALKYLATED OLIGOALKYLENEPOLYAMINES NDSU RESEARCH FOUNDATION 2012-11-15 US disclosed
US-8304553-B2 Method of forming oseltamivir and derivatives thereof NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-11-06 US disclosed
CN-102421451-A Bendamustine cyclopolysaccharide compositions SUPRATEK PHARMA INC 2012-04-18 CN disclosed
EP-2400987-A1 BENDAMUSTINE CYCLOPOLYSACCHARIDE COMPOSITIONS SUPRATEK PHARMA, INC. (CA) 2012-01-04 EP disclosed
WO-2011154827-A2 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF RHODES TECHNOLOGIES (US) 2011-12-15 WO disclosed
WO-2011104625-A1 CYCLOPOLYSACCHARIDE COMPOSITIONS SUPRATEK PHARMA, INC. (CA) 2011-09-01 WO disclosed
US-20110207764-A1 CYCLOPOLYSACCHARIDE COMPOSITIONS SUPRATEK PHARMA INC. (CA) 2011-08-25 US disclosed
WO-2011097490-A1 METHOD OF PRODUCING POLYALKYLATED OLIGOALKYLENEPOLYAMINES NDSU RESEARCH FOUNDATION (US) 2011-08-11 WO disclosed
WO-2011094191-A1 METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS NDSU RESEARCH FOUNDATION (US) 2011-08-04 WO disclosed
US-20110021762-A1 METHOD OF FORMING OSELTAMIVIR AND DERIVATIVES THEREOF NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2011-01-27 US disclosed
US-20110015245-A1 BENDAMUSTINE AMPHIPHILIC CATIONIC COMPOSITIONS SUPRATEK PHARMA INC. (CA) 2011-01-20 US disclosed
US-7816539-B2 Derivatives of benzimidazole and imidazo-pyridine and their use as medicaments IPSEN PHARMA S.A.S. (FR) 2010-10-19 US disclosed
WO-2010097700-A1 BENDAMUSTINE CYCLOPOLYSACCHARIDE COMPOSITIONS SUPRATEK PHARMA, INC. (CA) 2010-09-02 WO disclosed
US-20100216858-A1 BENDAMUSTINE CYCLOPOLYSACCHARIDE COMPOSITIONS SOFTKEMO PHARMA CORP. (CA) 2010-08-26 US disclosed
US-20090270372-A1 NOVEL DERIVATIVES OF BENZIMIDAZOLE AND IMIDAZO-PYRIDINE AND THEIR USE AS MEDICAMENTS SOCIETE DE CONSEILS DE RECHERCHES ET (FR) 2009-10-29 US disclosed
WO-2009078813-A1 METHOD OF FORMING OSELTAMIVIR AND DERIVATIVES THEREOF NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2009-06-25 WO disclosed
US-7501525-B2 Derivatives of benzimidazole and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-03-10 US disclosed
US-7495009-B2 Imidazopyridine derivatives as melancortin receptor agonists SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-02-24 US disclosed
US-20090035696-A1 PHOTORESIST COMPOSITION KYOWA HAKKO CHEMICAL CO., LTD. (JP) 2009-02-05 US disclosed
US-20080139619-A1 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS (S.C.R.A.S.) 2008-06-12 US disclosed
EP-1270248-B1 Sheet for ink jet recording FUJIFILM CORP (JP) 2007-03-21 EP disclosed
US-7163982-B2 Process for preparing fluorine-containing polymer and method of forming fine pattern using same DAIKI INDUSTRIES, LTD. (JP) 2007-01-16 US disclosed
US-20050049374-A1 Process for preparing fluorine-containing polymer and method of forming fine pattern using same DAIKIN INDUSTRIES, LTD 2005-03-03 US disclosed
US-20030026960-A1 Sheet for ink jet recording FUJI PHOTO FILM CO., LTD. 2003-02-06 US disclosed
EP-1270248-A2 Sheet for ink jet recording FUJI PHOTO FILM CO., LTD. (JP) 2003-01-02 EP disclosed
EP-1089974-A4 PROCESS TO PREPARE DIHYDROPYRIDINE AND DERIVATIVES THEREOF HOECHST CELANESE CORP (US) 2001-05-30 EP disclosed
EP-1089974-A1 PROCESS TO PREPARE DIHYDROPYRIDINE AND DERIVATIVES THEREOF Hoechst Celanese Corporation (US) 2001-04-11 EP disclosed
WO-2000032586-A1 METHOD FOR PREPARING 3-CHROMENE DERIVATIVES, USE OF SAID DERIVATIVES FOR PREPARING THIAZOLIDINONES RHODIA CHIMIE (FR) 2000-06-08 WO disclosed
US-5977369-A Process to prepare dihydropyridine and derivatives thereof NAPP TECHNOLOGIES, INC. (US) 1999-11-02 US disclosed
WO-1999006392-A1 METHOD FOR PREPARING 2H-1 BENZOPYRANES AND SYNTHESIS INTERMEDIATES RHODIA CHIMIE (FR) 1999-02-11 WO disclosed
EP-0882700-A2 Process for the production of the dexfenfluramine hydrochloride ALFA CHEMICALS ITALIANA S.p.A. (IT) 1998-12-09 EP disclosed
WO-1998041518-A1 METHOD FOR PREPARING 2H-1 BENZOPYRANES RHODIA CHIMIE (FR) 1998-09-24 WO disclosed
WO-1997024326-A1 PROCESS TO PREPARE DIHYDROPYRIDINE AND DERIVATIVES THEREOF HOECHST CELANESE CORPORATION (US) 1997-07-10 WO disclosed
US-5481038-A Borane-N,N-diisopropylalkylamine hydroboration agents ALDRICH CHEMICAL COMPANY, INC. (US) 1996-01-02 US disclosed
EP-0467727-B1 Esterification process of hydroxybenzoic acids RHONE POULENC CHIMIE (FR) 1995-09-13 EP disclosed
US-5260475-A Esterification of hydroxybenzoic acids RHONE-POULENC CHIMIE (FR) 1993-11-09 US disclosed
EP-0404619-B1 PROCESS FOR THE PRODUCTION OF N-MONOALKYL OR ALKENYL ANILINES RHONE-POULENC CHIMIE (FR) 1993-09-29 EP disclosed
US-5210305-A Process for preparing n-alkylanilines and n-allylanilines RHONE-POULENC CHIMIE (FR) 1993-05-11 US disclosed
US-5189220-A Reacting aniline and derivatives with alkyl/allyl halides or sulfates in a solvent in presence of alkali metal iodide or onium iodide and a nonqurtenizable base RHONE-POULENC CHIMIE (FR) 1993-02-23 US disclosed
US-5189218-A PREPARATION OF N-PHENYLBENZOQUINONE-IMINE AND CONVERTING SAME INTO P-PHENYLENEDIAMINES RHONE-POULENC CHIMIE (FR) 1993-02-23 US disclosed
US-5132460-A Contacting an aniline with alkyl or alkenyl halide in presence of non-quaternizable tertiary amine and salt of non-quaternizable tertiary amine RHONE-POULENC CHIMIE (FR) 1992-07-21 US disclosed
EP-0353131-B1 PROCESS FOR THE PREPARATION OF N-ALKYL AND N-ALLYL ANILINES RHONE-POULENC CHIMIE (FR) 1992-04-15 EP disclosed
EP-0353130-B1 PROCESS FOR THE PREPARATION OF N-ALLYL AND N-ALKYL ANILINES CATALYSED BY IODIDES RHONE-POULENC CHIMIE (FR) 1992-04-15 EP disclosed
EP-0467727-A1 Esterification process of hydroxybenzoic acids RHONE-POULENC CHIMIE (FR) 1992-01-22 EP disclosed
EP-0463922-A1 Process for the esterification of carboxylic acids RHONE-POULENC CHIMIE (FR) 1992-01-02 EP disclosed
EP-0404619-A1 Process for the production of n-monoalkyl or alkenyl anilines RHONE-POULENC CHIMIE (FR) 1990-12-27 EP disclosed
EP-0353130-A1 Process for the preparation of N-allyl and N-alkyl anilines catalysed by iodides RHONE-POULENC CHIMIE (FR) 1990-01-31 EP disclosed
EP-0353131-A1 Process for the preparation of N-alkyl and N-allyl anilines RHONE-POULENC CHIMIE (FR) 1990-01-31 EP disclosed
US-4118439-A IONICALLY CROSSLINKED QUATERNARY AMMONIUM POLYMER RHONE-POULENC S.A. (FR) 1978-10-03 US disclosed
US-4118439-A IONICALLY CROSSLINKED QUATERNARY AMMONIUM POLYMER RHONE-POULENC S.A. (FR) 1978-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (18 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12296325-B2 Catalyst for hydrosilylation reaction, hydrogenation reaction, and hydrosilane reduction reaction H1-0, HVCN1, H1-2 MEN1 441/4885KMT2A 1314/4885
US-20150336972-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF OPRK1, OPRM1, OPRD1 MEN1 3549/4885KMT2A 1892/4885
US-20090270372-A1 NOVEL DERIVATIVES OF BENZIMIDAZOLE AND IMIDAZO-PYRIDINE AND THEIR USE AS MEDICAMENTS MC4R, MC3R, MC1R MEN1 1273/4885KMT2A 1957/4885
US-20150353569-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF OPRK1, OPRM1, OPRD1 MEN1 3549/4885KMT2A 1892/4885
US-20200368355-A1 FORMULATIONS OF BENDAMUSTINE FOLR2, BHMT, THPO MEN1 873/4885KMT2A 935/4885
US-20180185488-A1 FORMULATIONS OF BENDAMUSTINE FOLR2, BHMT, THPO MEN1 873/4885KMT2A 935/4885
US-20170349675-A1 NEW POLYOLEFIN CATALYST AND USE THEREOF NOTUM, WEE1, FAR1 MEN1 2430/4885KMT2A 3463/4885
US-20120289748-A1 METHOD OF PRODUCING POLYALKYLATED OLIGOALKYLENEPOLYAMINES PHOSPHO1, POLL, ALK MEN1 3098/4885KMT2A 2102/4885
US-20230241594-A1 CATALYST FOR HYDROSILYLATION REACTION, HYDROGENATION REACTION, AND HYDROSILANE REDUCTION REACTION H1-0, HVCN1, H1-2 MEN1 441/4885KMT2A 1314/4885
US-20220389133-A1 METALLOCENE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF PPIL4, PIN1, PPIL1 MEN1 442/4885KMT2A 2269/4885
US-20080139619-A1 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments MC4R, MC1R, MC3R MEN1 1306/4885KMT2A 2240/4885
US-20120316201-A1 NOVEL BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AND USE THEREOF AS A MEDICAMENT MC4R, MC5R, MC1R MEN1 970/4885KMT2A 1386/4885
US-20130102780-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF OPRK1, OPRM1, OPRD1 MEN1 3549/4885KMT2A 1892/4885
US-20150353567-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF OPRK1, OPRM1, OPRD1 MEN1 3549/4885KMT2A 1892/4885
US-20110021762-A1 METHOD OF FORMING OSELTAMIVIR AND DERIVATIVES THEREOF AOC1, ALK, ALDH3A1 MEN1 4561/4885KMT2A 1943/4885
US-20150353568-A1 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF OPRK1, OPRM1, OPRD1 MEN1 3549/4885KMT2A 1892/4885
US-20240148696-A1 LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION SORD, SBK1, SBDS MEN1 387/4885KMT2A 3987/4885
US-20220401938-A1 CATALYST FOR HYDROSILYLATION REACTION, HYDROGENATION REACTION, AND HYDROSILANE REDUCTION REACTION H1-0, HVCN1, H1-2 MEN1 439/4885KMT2A 1306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.